Innovate UK

www.gov.uk/government/organisations/innovate-uk

North Star House
North Star Avenue
Swindon
Wiltshire
SN2 1UE
United Kingdom

+44 1793 442700

Activities

Research & Development | Finance

Related Companies

Related Content

Start-up receives Innovate UK funding for intraocular lens implant
Start-up receives Innovate UK funding for intraocular lens implant
Innovate UK funds biologics manufacturing consortium
Innovate UK funds biologics manufacturing consortium
Ingenza receives grant from Eureka and Innovate UK
Ingenza receives grant from Eureka and Innovate UK
Turntable-like catalytic reactor wins Innovate funding
Turntable-like catalytic reactor wins Innovate funding
Atelerix secures Innovate UK funding for cell transport tech
Atelerix secures Innovate UK funding for cell transport tech
Research partnership removes bottleneck from AAV development
Research partnership removes bottleneck from AAV development
UK government releases £125 million in grant funding to support innovators
UK government releases £125 million in grant funding to support innovators
ManChem funding roundup
ManChem funding roundup
Collaboration funds asthma diagnosis projects in the UK
Collaboration funds asthma diagnosis projects in the UK
Surge in cell and gene therapy trials highlight the UK’s leading position as developmental hub in this innovative industry
Surge in cell and gene therapy trials highlight the UK’s leading position as developmental hub in this innovative industry
CGT Catapult addresses skills gap with apprenticeship programme for advanced therapies
CGT Catapult addresses skills gap with apprenticeship programme for advanced therapies
Almac Discovery, Elasmogen and Innovate UK collaborate
Almac Discovery, Elasmogen and Innovate UK collaborate
Phico Therapeutics awarded Innovate UK funding
Phico Therapeutics awarded Innovate UK funding
£10m research competition to tackle antimicrobial resistance
£10m research competition to tackle antimicrobial resistance
Funding to support novel cancer immunotherapy programme
Funding to support novel cancer immunotherapy programme